Your trusted source for investing success

Tag: approval process

Looking for Cannabis Stocks?

Read our report to find market data, important news and stocks to watch!
 
Lexaria Bioscience Corp. Receives New U.S. Patent Allowance for Cannabinoid Delivery and Updates its Expanding Patent Portfolio

Lexaria Bioscience Corp. Receives New U.S. Patent Allowance for Cannabinoid Delivery and Updates its Expanding Patent Portfolio

Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP), a drug delivery platform innovator, announces it has received another new Notice of Allowance from the United States Patent and Trademark Office (“USPTO”) providing claims that protect processes for making specific compositions of matter for enhanced cannabinoid delivery utilizing its DehydraTECH(TM) technology.

HPQ Signs MOU with Big Data Enterprise Blockchain Solution Developer to Develop a Carbon Credit Marketplace for Solar Carbon Credits Generated by its PUREVAP™ Process

HPQ Signs MOU with Big Data Enterprise Blockchain Solution Developer to Develop a Carbon Credit Marketplace for Solar Carbon Credits Generated by its PUREVAP™ Process

HPQ Silicon Resources Inc. (TSXV:HPQ) is pleased to inform shareholders that its newly created subsidiary, Solar Blockchain Energies Inc. (“SBEI”), has entered into a Memorandum of Understanding (“MOU”) with an Undisclosed Blockchain Company (“UBC”) to advise, develop and implement a new set of blockchain solutions for the monetization of solar

10 Small-cap Cannabis Stocks

10 Small-cap Cannabis Stocks

What are the small-cap cannabis stocks on the market? And which could be the next to make gains? Our overview includes details on a variety of companies.

Lexaria Bioscience Corp. Receives New U.S. Patent Allowance for “Composition of Matter” Cannabinoid Delivery

Lexaria Bioscience Corp. Receives New U.S. Patent Allowance for “Composition of Matter” Cannabinoid Delivery

Lexaria Bioscience Corp. (CSE:LXX,OTCQB:LXRP) (the “Company” or “Lexaria”), a drug delivery platform innovator, announces it has received a new Notice of Allowance from the United States Patent and Trademark Office (“USPTO”) providing for “composition of matter” claims that protect the specific combination of substances which enable improved taste and bioabsorption

BioSyent Releases Results for Fourth Quarter and Full Year 2017

BioSyent (TSXV:RX) released today a summary of its financial results for the three and twelve months ended December 31, 2017.

As quoted in the press release:
“BioSyent had a strong finish to 2017 with both our Canadian and International Pharmaceutical businesses posting record quarterly sales in Q4,” commented René Goehrum, President and

Vodis Pharmaceuticals Provides Investor Update

Vodis Pharmaceuticals Provides Investor Update

Vodis Pharmaceuticals Inc. (CSE:VP,FSE:1JV1) (“Vodis” or the “Company”) provides an update on operations in Canada and the United States. Since the fall of 2017, the Company’s Canadian operations have met the challenges of working capital requirements while it navigated the Health Canada licensing approval process.

Are You Aware of the FDA's Plans for 2018?

Find out what's going on in our new report
 
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Cannabis Weekly Round-Up: New Merger in the Public Markets

URL: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/cannabis-weekly-roundup/